These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 24384535
21. Intraoperative anesthetic management of the liver transplant recipient with portopulmonary hypertension. Kandil S. Curr Opin Organ Transplant; 2019 Apr; 24(2):121-130. PubMed ID: 30762664 [Abstract] [Full Text] [Related]
22. Portopulmonary Hypertension in Liver Disease Presenting in Childhood. Ecochard-Dugelay E, Lambert V, Schleich JM, Duché M, Jacquemin E, Bernard O. J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):346-54. PubMed ID: 25885880 [Abstract] [Full Text] [Related]
23. Portopulmonary hypertension and hepatopulmonary syndrome. Aldenkortt F, Aldenkortt M, Caviezel L, Waeber JL, Weber A, Schiffer E. World J Gastroenterol; 2014 Jul 07; 20(25):8072-81. PubMed ID: 25009379 [Abstract] [Full Text] [Related]
24. Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation. Scouras NE, Matsusaki T, Boucek CD, Wells C, Cooper EA, Planinsic RM, Sullivan EA, Bermudez CA, Toyoda Y, Sakai T. Liver Transpl; 2011 Feb 07; 17(2):137-43. PubMed ID: 21280186 [Abstract] [Full Text] [Related]
26. Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates. Torregrosa M, Genesca J, Gonzalez A, Evangelista A, Mora A, Margarit C, Esteban R, Guardia J. Transplantation; 2001 Feb 27; 71(4):572-4. PubMed ID: 11258439 [Abstract] [Full Text] [Related]
28. Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease. Wakabayashi SI, Joshita S, Kimura K, Motoki H, Kobayashi H, Yamashita Y, Sugiura A, Yamazaki T, Kuwahara K, Umemura T. PLoS One; 2021 Feb 27; 16(4):e0249435. PubMed ID: 33793649 [Abstract] [Full Text] [Related]
29. Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of portopulmonary hypertension. Chiva T, Ripoll C, Sarnago F, Rincón D, Gómez-Camarero J, Galindo E, Catalina MV, Elizaga J, Bañares R. Liver Int; 2015 Feb 27; 35(2):353-61. PubMed ID: 24797536 [Abstract] [Full Text] [Related]
30. Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature. Cosarderelioglu C, Cosar AM, Gurakar M, Pustavoitau A, Russell SD, Dagher NN, Gurakar A. Exp Clin Transplant; 2016 Apr 27; 14(2):113-20. PubMed ID: 27015528 [Abstract] [Full Text] [Related]
31. Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. Cartin-Ceba R, Swanson K, Iyer V, Wiesner RH, Krowka MJ. Chest; 2011 Jan 27; 139(1):109-14. PubMed ID: 20705798 [Abstract] [Full Text] [Related]
32. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension. Kähler CM, Graziadei I, Wiedermann CJ, Kneussl MP, Vogel W. Wien Klin Wochenschr; 2000 Jul 28; 112(14):637-40. PubMed ID: 11008327 [Abstract] [Full Text] [Related]
34. Long-term outcome in liver transplantation candidates with portopulmonary hypertension. Savale L, Sattler C, Coilly A, Conti F, Renard S, Francoz C, Bouvaist H, Feray C, Borentain P, Jaïs X, Montani D, Parent F, O'Connell C, Hervé P, Humbert M, Simonneau G, Samuel D, Calmus Y, Duvoux C, Durand F, Duclos-Vallée JC, Sitbon O. Hepatology; 2017 May 28; 65(5):1683-1692. PubMed ID: 27997987 [Abstract] [Full Text] [Related]
35. Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates. Hayashi R, Kogiso T, Kikuchi N, Yamamoto K, Nakamura S, Egawa H, Hagiwara N, Tokushige K. PLoS One; 2022 May 28; 17(4):e0267125. PubMed ID: 35439259 [Abstract] [Full Text] [Related]
36. Pulmonary Hypertension Improves After Orthotopic Liver Transplant in Patients With Chronic Liver Disease. Savaş Bozbaş Ş, Eroğlu S, Öner Eyüboğlu F, Moray G, Haberal M. Exp Clin Transplant; 2015 Nov 28; 13 Suppl 3():115-9. PubMed ID: 26640929 [Abstract] [Full Text] [Related]
37. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Krowka MJ. Clin Chest Med; 2005 Dec 28; 26(4):587-97, vi. PubMed ID: 16263398 [Abstract] [Full Text] [Related]
38. Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension. Legros L, Chabanne C, Camus C, Fournet M, Houssel-Debry P, Latournerie M, Jezequel C, Rayar M, Boudjema K, Guyader D, Bardou-Jacquet E. Dig Liver Dis; 2017 Mar 28; 49(3):301-307. PubMed ID: 27840058 [Abstract] [Full Text] [Related]
39. Hemodynamic and Clinical Response to Liver Transplantation in Children and Young Adults POPH Patients. Baba S, Ogawa E, Akagi K, Matsuda K, Hirata T, Okamoto T, Okajima H, Takita J. Pediatr Cardiol; 2024 Jun 28; 45(5):1142-1150. PubMed ID: 36754885 [Abstract] [Full Text] [Related]
40. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Kim WR, Krowka MJ, Plevak DJ, Lee J, Rettke SR, Frantz RP, Wiesner RH. Liver Transpl; 2000 Jul 28; 6(4):453-8. PubMed ID: 10915168 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]